GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING Trademark
Trademark Overview
On Friday, January 17, 2025, a trademark application was filed for GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING with the United States Patent and Trademark Office. The USPTO has given the GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING trademark a serial number of 99008053. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 31, 2025. This trademark is owned by Oncocyte Corporation. The GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in disease, condition and infection detection; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in in vitro diagnostic (IVD) testing
Medical testing for transplantation monitoring and transplantation therapy evaluation
General Information
| Serial Number | 99008053 |
| Word Mark | GRAFT ASSURE DX DECENTRALIZED TRANSPLANT MONITORING |
| Filing Date | Friday, January 17, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, March 31, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the wording "Graft" followed "Assure" each in black, separated by a double helix design, followed by the word "Dx" within a red square having a curved upper left and lower right corner, all stacked over the wording "Decentralized Transplant Monitoring" in smaller size font wherein "Decentralized" is in red, and "Transplant Monitoring" is in black. |
| Goods and Services | Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in disease, condition and infection detection; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in in vitro diagnostic (IVD) testing |
| Indication of Colors claimed | The color(s) Black and Red is/are claimed as a feature of the mark. |
| Goods and Services | Medical testing for transplantation monitoring and transplantation therapy evaluation |
| NOT AVAILABLE | "TRANSPLANT MONITORING" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Oncocyte Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
Trademark Events
| Event Date | Event Description |
| Friday, January 17, 2025 | NEW APPLICATION ENTERED |
| Sunday, March 30, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, March 30, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 31, 2025 | ASSIGNED TO EXAMINER |
| Monday, March 31, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, March 31, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 31, 2025 | NON-FINAL ACTION E-MAILED |
